Resultado de búsqueda
Physician-scientist and gene therapy pioneer, Dr. Katherine High, had a long career as an academic hematologist studying hemophilias and gene therapy vectors, before moving into industry. In both realms, High ( Figure 1) played a massive role in bringing forward the first FDA-approved gene therapy. To hear more about isolating and cloning genes ...
Viral vector systems, based on adeno-associated viruses and lentiviruses, are ideally suited to mediate RNAi because they can safely transduce a wide range of tissues and provide sustained levels of gene expression. There are now many examples of the use of viral vector-mediated RNAi to inhibit gene expression in animal models of disease, and ...
Katherine High School 3 days ago CDU - Katherine Open Day Saturday 25 May - 9 am to 1 pm, CDU Katherine Rural Campus, Lot 5626 (16km North of Katherine), Stuart Highway, Katherine NT 0850 Learn something new at Katherine Open Day.
Katherine High biography. Dr. Katherine A. High M.D. serves as Independent Director of the Company. She served as President of Spark Therapeutics, Inc., a gene therapy company, from September 2014 until February 2020 and served as Head of Research and Development of Spark from September 2017 until February 2020.
22 de nov. de 2016 · Katherine and her husband decided to move the family to Newport News, Virginia, to pursue the opportunity, and Katherine began work at Langley in the summer of 1953. Just two weeks into her tenure in the office, Dorothy Vaughan assigned her to a project in the Maneuver Loads Branch of the Flight Research Division, and Katherine’s temporary position soon became permanent.
Dr. Katherine A. High is a Pediatric Hematologist-Oncologist in Philadelphia, PA. Find Dr. High's phone number, address, insurance information, hospital affiliations and more.
12 de ene. de 2018 · After almost 30 years of promise tempered by setbacks, gene therapies are rapidly becoming a critical component of the therapeutic armamentarium for a variety of inherited and acquired human diseases. Gene therapies for inherited immune disorders, hemophilia, eye and neurodegenerative disorders, and lymphoid cancers recently progressed to ...
